NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000044128

Registered date:07/05/2021

Anxiety to SARS-CoV-2 vaccine in patients with autoimmune liver disease and effect of information sharing

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedAutoimmune liver disease
Date of first enrollment2021/05/06
Target sample size50
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Providing information about COVID19 and vaccines to SARS-CoV-2

Outcome(s)

Primary OutcomeInformation sharing improves objective parameter of anxiety to the vaccination.
Secondary OutcomeEffect of information sharing to decision of vaccine receiving.

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum100years-old
GenderMale and Female
Include criteria
Exclude criteriaWithout informed assent to be participant in this study

Related Information

Contact

public contact
Name Keisuke Kakisaka
Address Idaidori 1-1-1, Yahaba cho, Iwate Japan 0283694
Telephone 0196515111
E-mail keikaki@iwate-med.ac.jp
Affiliation Iwate Medical University Division of Hepatology, Department of Internal Medicine
scientific contact
Name Yasuhiro Takikawa
Address Idaidori 1-1-1, Yahaba cho, Iwate Japan
Telephone 0196515111
E-mail ytakikaw@iwate-med.ac.jp
Affiliation Iwate Medical University Division of Hepatology, Department of Internal Medicine